The Navy commissioned David Schmidt, founder of Advanced Applications Group, to create a device for sailors to enhance their physical capabilities. This initiative led to the development of LifeWave’s X39 patch, marketed as a wearable light technology that stimulates cellular regeneration. The product, initially designed for military use, has since gained attention for its purported ability to activate stem cells and address age-related decline.

Users report rapid improvements in health issues such as chronic pain, joint stiffness, and fatigue. One individual described the elimination of persistent lower back discomfort within days, while another noted reduced knee inflammation after three weeks. Testimonials also highlight the patch’s potential to reverse signs of aging, with claims of improved skin tone and mobility.

The technology is said to work by triggering the production of GHK-cu, a copper peptide linked to cellular repair. LifeWave offers additional patches, including the Aeon patch for inflammation reduction and IceWave for acute pain relief. Despite its popularity, the product faces skepticism from mainstream medical institutions, which have not validated its efficacy through clinical trials.

Promotional materials emphasize cost-effectiveness compared to expensive treatments like stem cell injections, while critics argue such claims lack scientific backing. The company encourages users to explore alternatives, including international medical procedures, though it positions its patches as a more accessible solution.

No independent verification of the product’s benefits has been publicly disclosed, and regulatory agencies have not endorsed its use for therapeutic purposes. Users are advised to consult healthcare professionals before purchasing.